default author photo

Sandro Santagata

Harvard Medical School - Department of Pathology

75 Francis St.

Boston, MA 02115

United States

SCHOLARLY PAPERS

5

DOWNLOADS

431

TOTAL CITATIONS

4

Scholarly Papers (5)

1.

The Impact of TERT Promoter Mutation on Meningioma Outcome is Context-Dependent: Implications for Clinical Grading and Risk Stratification

Number of pages: 27 Posted: 31 Jan 2025
New York University (NYU) - NYU Langone Health, Harvard University, New York University (NYU) - NYU Langone Health, Harvard University, Yale University, Yale University, University of California, San Francisco (UCSF), Baylor University, New York University (NYU) - NYU Langone Health, Northwestern University - Feinberg School of Medicine, Northwestern University - Feinberg School of Medicine, Northwestern University - Feinberg School of Medicine, Harvard University, University of Toronto, University of Toronto, University of Pennsylvania, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Heidelberg University - University Hospital Heidelberg, University of Hamburg - University Cancer Center Hamburg, Harvard University, University of Hamburg - Institute of Neuropathology, Harvard Medical School - Department of Pathology, Heidelberg University - University Hospital Heidelberg, Memorial Sloan Kettering Cancer Center, University of Pennsylvania, Mount Sinai Health System - Icahn School of Medicine, University of Texas at Dallas - Southwestern Medical Center, University of Toronto - Unity Health Toronto, University of Toronto, Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin, Northwestern University - Feinberg School of Medicine, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health, Baylor University, University of California, San Francisco (UCSF), Yale University, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health and Harvard University
Downloads 176 (428,796)

Abstract:

Loading...

meningioma, tert promoter mutation, CDKN2A/B deletion, WHO grading

2.

Antigen Dominance Hierarchies Shape TCF1+ Progenitor CD8 T Cell Phenotypes in Tumors

Number of pages: 89 Posted: 20 Jan 2021
Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Sanofi - Massachusetts, Harvard Medical School - Department of Pathology, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, MIT McGovern Institute for Brain Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard Medical School - Department of Pathology and Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research
Downloads 132 (551,165)

Abstract:

Loading...

TCF1; neoantigen; immunodominance; CCR6; Tc17; vaccine; lung cancer

3.

The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single Cell Resolution

Number of pages: 78 Posted: 07 Jun 2021
Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Department of Pathology, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Dana-Farber Cancer Institute, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Department of Pathology, Harvard University - Program in Dermatopathology, Harvard Medical School - Department of Pathology and Harvard University - Laboratory of Systems Pharmacology
Downloads 48 (1,086,013)
Citation 4

Abstract:

Loading...

4.

2D and 3D Multiplexed Subcellular Profiling of Nuclear Instability in Human Cancer

Number of pages: 40 Posted: 07 Nov 2023
Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, University of Pittsburgh, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Dana-Farber Cancer Institute, Harvard University - Harvard Medical School, University of Chicago, Harvard University - Harvard Medical School, Harvard University - Dana-Farber Cancer Institute, Harvard University - Harvard Medical School, Harvard University - Dana-Farber Cancer Institute, Harvard University - Laboratory of Systems Pharmacology, Harvard Medical School - Department of Pathology and Independent
Downloads 40 (1,183,237)

Abstract:

Loading...

Glioblastoma, lamins, DNA damage, neoplasms, inflammation, cGAS, STING, immunofluorescence, Pathology, multiplexed imaging, systems biology, computational biology, spatial analysis, spatial correlation, CyCIF, fluorescence microscopy, animal models, molecular pathology

5.

Lymphocyte Networks are Dynamic Cellular Communities in the Immunoregulatory Landscape of Lung Adenocarcinoma

Number of pages: 68 Posted: 12 Aug 2022
Sanofi - Massachusetts, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, MIT McGovern Institute for Brain Research, Harvard University - School of Engineering and Applied Sciences, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - School of Engineering and Applied Sciences, Harvard University - Laboratory of Systems Pharmacology, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research and Harvard Medical School - Department of Pathology
Downloads 35 (1,249,711)

Abstract:

Loading...

multiplexed imaging, systems biology, computational biology, temporal inference, spatial analysis, spatio-temporal analysis, spatial correlation, CyCIF, fluorescence microscopy, Neoplasms, adenocarcinoma of lung, lung neoplasms, Immunotherapy, Cancer vaccines, immune checkpoint inhibitors, Programmed Cell Death 1 Receptor, animal models, Pathology, molecular pathology